Global Radiopharmaceuticals in Nuclear Medicine Market Professional Survey Report 2018

Publisher : XYZResearch Publication Date : Jun 12, 2018

Number of Pages : 126 Subcategory : Pharmaceuticals
Single User $ 2800
Global User $ 5500

Want to have a look at sample?

Request sample

Want to check today's discount?

Enquiry for Discount
  • Description

    Product Description

    This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Bracco Imaging S.P.A.
    Cambridge Isotope Laboratories, Inc.
    Cardinal Health, Inc.
    Covidien, Plc
    Eczacibasi-Monrol
    Fujifilm Holdings Corporation
    GE Healthcare (Subsidiary Of General Electric Company)
    IBA Group
    Isotec, Inc. (Sigma-Aldrich)
    Lantheus Medical Imaging, Inc.
    Nordion, Inc.
    Ntp Radioisotopes (Pty), Ltd.
    Siemens Healthcare (Subsidiary Of Siemens AG)
    Taiyo Nippon Sanso Corporation
    Urenco Limited

    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Diagnostic Radiopharmaceuticals
    Therapy Radiopharmaceuticals
    Enriched Stable Isotopes

    By Application, the market can be split into
    Diagnostic Application
    Therapeutic Application
    Research
    Pharmaceutical
    Other

    By Regions, this report covers (we can add the regions/countries as you want)
    North America
    Europe
    China
    Japan
    Southeast Asia
    India

    If you have any special requirements, please let us know and we will offer you the report as you want.

  • Table of Content

    Global Radiopharmaceuticals in Nuclear Medicine Market Professional Survey Report 2018

    Table of Contents

    Global Radiopharmaceuticals in Nuclear Medicine Market Professional Survey Report 2017
    1 Industry Overview of Radiopharmaceuticals in Nuclear Medicine
    1.1 Definition and Specifications of Radiopharmaceuticals in Nuclear Medicine
    1.1.1 Definition of Radiopharmaceuticals in Nuclear Medicine
    1.1.2 Specifications of Radiopharmaceuticals in Nuclear Medicine
    1.2 Classification of Radiopharmaceuticals in Nuclear Medicine
    1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Production (K Units) and Growth Rate (%) Comparison by Types (2012-2023)
    1.2.2 Global Radiopharmaceuticals in Nuclear Medicine Production Market Share (%) by Types in 2017
    1.2.3 Diagnostic Radiopharmaceuticals
    1.2.4 Therapy Radiopharmaceuticals
    1.2.5 Enriched Stable Isotopes
    1.3 Applications of Radiopharmaceuticals in Nuclear Medicine
    1.3.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption (K Units) Comparison by Applications (2012-2023)
    1.3.2 Diagnostic Application
    1.3.3 Therapeutic Application
    1.3.4 Research
    1.3.5 Pharmaceutical
    1.3.6 Other
    1.4 Global Radiopharmaceuticals in Nuclear MedicineMarket by Regions (2012-2023)
    1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (%) Comparison by Regions (2012-2023)
    1.4.2 North AmericaRadiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2023)
    1.4.3 EuropeRadiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2023)
    1.4.4 ChinaRadiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2023)
    1.4.5 JapanRadiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2023)
    1.4.6 Southeast AsiaRadiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2023)
    1.5 Global Radiopharmaceuticals in Nuclear Medicine Market Size (2012-2023)
    1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Status and Outlook (2012-2023)
    1.5.2 Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units) Status and Outlook (2012-2023)

    2 Industrial Chain Analysis
    2.1 Industry Chain Structure of Radiopharmaceuticals in Nuclear Medicine
    2.2 Raw Material Analysis of Radiopharmaceuticals in Nuclear Medicine
    2.2.1 Raw Material A Market Analysis
    2.2.2 Raw Material B Market Analysis
    2.2.3 Raw Material C Market Analysis
    2.3 Labor Cost Analysis of Radiopharmaceuticals in Nuclear Medicine
    2.4 Other Costs Analysis of Radiopharmaceuticals in Nuclear Medicine
    2.5 Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medicine
    2.6 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
    2.7 Raw Materials Sources of Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2017
    2.8 Downstream Buyers of Radiopharmaceuticals in Nuclear Medicine

    3 Global Radiopharmaceuticals in Nuclear Medicine Manufacturers Profiles/Analysis
    3.1 Bracco Imaging S.P.A.
    3.1.1 Company Basic Information, Manufacturing Base and Competitors
    3.1.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    3.1.2.1 Diagnostic Radiopharmaceuticals
    3.1.2.2 Therapy Radiopharmaceuticals
    3.1.2.3 Enriched Stable Isotopes
    3.1.3 Bracco Imaging S.P.A. 2017 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.1.4 Bracco Imaging S.P.A. 2017 Business Region Distribution Analysis
    3.1.5 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Volume in Different Applications and Its Application Share
    3.2 Cambridge Isotope Laboratories, Inc.
    3.2.1 Company Basic Information, Manufacturing Base and Competitors
    3.2.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    3.2.2.1 Diagnostic Radiopharmaceuticals
    3.2.2.2 Therapy Radiopharmaceuticals
    3.2.2.3 Enriched Stable Isotopes
    3.2.3 Cambridge Isotope Laboratories, Inc. 2017 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.2.4 Cambridge Isotope Laboratories, Inc. 2017 Business Region Distribution Analysis
    3.2.5 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Volume in Different Applications and Its Application Share
    3.3 Cardinal Health, Inc.
    3.3.1 Company Basic Information, Manufacturing Base and Competitors
    3.3.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    3.3.2.1 Diagnostic Radiopharmaceuticals
    3.3.2.2 Therapy Radiopharmaceuticals
    3.3.2.3 Enriched Stable Isotopes
    3.3.3 Cardinal Health, Inc. 2017 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.3.4 Cardinal Health, Inc. 2017 Business Region Distribution Analysis
    3.3.5 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Volume in Different Applications and Its Application Share
    3.4 Covidien, Plc
    3.4.1 Company Basic Information, Manufacturing Base and Competitors
    3.4.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    3.4.2.1 Diagnostic Radiopharmaceuticals
    3.4.2.2 Therapy Radiopharmaceuticals
    3.4.2.3 Enriched Stable Isotopes
    3.4.3 Covidien, Plc 2017 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.4.4 Covidien, Plc 2017 Business Region Distribution Analysis
    3.4.5 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Volume in Different Applications and Its Application Share
    3.5 Eczacibasi-Monrol
    3.5.1 Company Basic Information, Manufacturing Base and Competitors
    3.5.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    3.5.2.1 Diagnostic Radiopharmaceuticals
    3.5.2.2 Therapy Radiopharmaceuticals
    3.5.2.3 Enriched Stable Isotopes
    3.5.3 Eczacibasi-Monrol 2017 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.5.4 Eczacibasi-Monrol 2017 Business Region Distribution Analysis
    3.5.5 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Volume in Different Applications and Its Application Share
    3.6 Fujifilm Holdings Corporation
    3.6.1 Company Basic Information, Manufacturing Base and Competitors
    3.6.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    3.6.2.1 Diagnostic Radiopharmaceuticals
    3.6.2.2 Therapy Radiopharmaceuticals
    3.6.2.3 Enriched Stable Isotopes
    3.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.6.4 Fujifilm Holdings Corporation 2017 Business Region Distribution Analysis
    3.6.5 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Volume in Different Applications and Its Application Share
    3.7 GE Healthcare (Subsidiary Of General Electric Company)
    3.7.1 Company Basic Information, Manufacturing Base and Competitors
    3.7.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    3.7.2.1 Diagnostic Radiopharmaceuticals
    3.7.2.2 Therapy Radiopharmaceuticals
    3.7.2.3 Enriched Stable Isotopes
    3.7.3 GE Healthcare (Subsidiary Of General Electric Company) 2017 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.7.4 GE Healthcare (Subsidiary Of General Electric Company) 2017 Business Region Distribution Analysis
    3.7.5 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Volume in Different Applications and Its Application Share
    3.8 IBA Group
    3.8.1 Company Basic Information, Manufacturing Base and Competitors
    3.8.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    3.8.2.1 Diagnostic Radiopharmaceuticals
    3.8.2.2 Therapy Radiopharmaceuticals
    3.8.2.3 Enriched Stable Isotopes
    3.8.3 IBA Group 2017 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.8.4 IBA Group 2017 Business Region Distribution Analysis
    3.8.5 IBA Group Radiopharmaceuticals in Nuclear Medicine Volume in Different Applications and Its Application Share
    3.9 Isotec, Inc. (Sigma-Aldrich)
    3.9.1 Company Basic Information, Manufacturing Base and Competitors
    3.9.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    3.9.2.1 Diagnostic Radiopharmaceuticals
    3.9.2.2 Therapy Radiopharmaceuticals
    3.9.2.3 Enriched Stable Isotopes
    3.9.3 Isotec, Inc. (Sigma-Aldrich) 2017 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.9.4 Isotec, Inc. (Sigma-Aldrich) 2017 Business Region Distribution Analysis
    3.9.5 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Volume in Different Applications and Its Application Share
    3.10 Lantheus Medical Imaging, Inc.
    3.10.1 Company Basic Information, Manufacturing Base and Competitors
    3.10.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    3.10.2.1 Diagnostic Radiopharmaceuticals
    3.10.2.2 Therapy Radiopharmaceuticals
    3.10.2.3 Enriched Stable Isotopes
    3.10.3 Lantheus Medical Imaging, Inc. 2017 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.10.4 Lantheus Medical Imaging, Inc. 2017 Business Region Distribution Analysis
    3.10.5 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Volume in Different Applications and Its Application Share
    3.11 Nordion, Inc.
    3.12 Ntp Radioisotopes (Pty), Ltd.
    3.13 Siemens Healthcare (Subsidiary Of Siemens AG)
    3.14 Taiyo Nippon Sanso Corporation
    3.15 Urenco Limited

    4 Technical Data and Manufacturing Plants Analysis of Radiopharmaceuticals in Nuclear Medicine
    4.1 Capacity and Commercial Production Date of Global Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2017
    4.2 Manufacturing Plants Distribution of Global Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2017
    4.4 R&D Status and Technology Source of Global Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2017
    4.4 Raw Materials Sources Analysis of Global Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2017

    5 Global Radiopharmaceuticals in Nuclear Medicine Overall Market Overview
    5.1 2012-2017 Overall Market Analysis
    5.2 Capacity Analysis
    5.2.1 2012-2017 Global Radiopharmaceuticals in Nuclear Medicine Capacity and Growth Rate Analysis
    5.2.2 2017 Radiopharmaceuticals in Nuclear Medicine Capacity Analysis (Company Segment)
    5.3 Sales Analysis
    5.3.1 2012-2017 Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate Analysis
    5.3.2 2017 Radiopharmaceuticals in Nuclear Medicine Sales Analysis (Company Segment)
    5.4 Sales Price Analysis
    5.4.1 2012-2017 Global Radiopharmaceuticals in Nuclear Medicine Sales Price
    5.4.2 2017 Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis (Company Segment)

    6 Radiopharmaceuticals in Nuclear Medicine Regional Market Analysis
    6.1 North America Radiopharmaceuticals in Nuclear Medicine Market Analysis
    6.1.1 North America Radiopharmaceuticals in Nuclear Medicine Market Overview
    6.1.2 North America 2012-2017 Radiopharmaceuticals in Nuclear Medicine Local Supply, Import, Export, Local Consumption Analysis
    6.1.3 North America 2012-2017 Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis
    6.1.4 North America 2017 Radiopharmaceuticals in Nuclear Medicine Market Share Analysis
    6.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Analysis
    6.2.1 Europe Radiopharmaceuticals in Nuclear Medicine Market Overview
    6.2.2 Europe 2012-2017 Radiopharmaceuticals in Nuclear Medicine Local Supply, Import, Export, Local Consumption Analysis
    6.2.3 Europe 2012-2017 Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis
    6.2.4 Europe 2017 Radiopharmaceuticals in Nuclear Medicine Market Share Analysis
    6.3 China Radiopharmaceuticals in Nuclear Medicine Market Analysis
    6.3.1 China Radiopharmaceuticals in Nuclear Medicine Market Overview
    6.3.2 China 2012-2017 Radiopharmaceuticals in Nuclear Medicine Local Supply, Import, Export, Local Consumption Analysis
    6.3.3 China 2012-2017 Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis
    6.3.4 China 2017 Radiopharmaceuticals in Nuclear Medicine Market Share Analysis
    6.4 Japan Radiopharmaceuticals in Nuclear Medicine Market Analysis
    6.4.1 Japan Radiopharmaceuticals in Nuclear Medicine Market Overview
    6.4.2 Japan 2012-2017 Radiopharmaceuticals in Nuclear Medicine Local Supply, Import, Export, Local Consumption Analysis
    6.4.3 Japan 2012-2017 Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis
    6.4.4 Japan 2017 Radiopharmaceuticals in Nuclear Medicine Market Share Analysis
    6.5 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Analysis
    6.5.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Overview
    6.5.2 Southeast Asia 2012-2017 Radiopharmaceuticals in Nuclear Medicine Local Supply, Import, Export, Local Consumption Analysis
    6.5.3 Southeast Asia 2012-2017 Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis
    6.5.4 Southeast Asia 2017 Radiopharmaceuticals in Nuclear Medicine Market Share Analysis
    6.6 India Radiopharmaceuticals in Nuclear Medicine Market Analysis
    6.6.1 India Radiopharmaceuticals in Nuclear Medicine Market Overview
    6.6.2 India 2012-2017 Radiopharmaceuticals in Nuclear Medicine Local Supply, Import, Export, Local Consumption Analysis
    6.6.3 India 2012-2017 Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis
    6.6.4 India 2017 Radiopharmaceuticals in Nuclear Medicine Market Share Analysis

    7 Global 2012-2017 Radiopharmaceuticals in Nuclear Medicine Segment Market Analysis (by Type)
    7.1 Global 2012-2017 Radiopharmaceuticals in Nuclear Medicine Sales by Type
    7.2 Different Types of Radiopharmaceuticals in Nuclear Medicine Product Interview Price Analysis
    7.3 Different Types of Radiopharmaceuticals in Nuclear Medicine Product Driving Factors Analysis
    7.3.1 Diagnostic Radiopharmaceuticals of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis
    7.3.2 Therapy Radiopharmaceuticals of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis
    7.3.3 Enriched Stable Isotopes of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis

    8 Global 2012-2017 Radiopharmaceuticals in Nuclear Medicine Segment Market Analysis (by Application)
    8.1 Global 2012-2017 Radiopharmaceuticals in Nuclear Medicine Consumption by Application
    8.2 Different Application of Radiopharmaceuticals in Nuclear Medicine Product Interview Price Analysis
    8.3 Different Application of Radiopharmaceuticals in Nuclear Medicine Product Driving Factors Analysis
    8.3.1 Diagnostic Application of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis
    8.3.2 Therapeutic Application of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis
    8.3.3 Research of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis
    8.3.4 Pharmaceutical of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis
    8.3.5 Other of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis

    9 Development Trend of Analysis of Radiopharmaceuticals in Nuclear Medicine Market
    9.1 Global Radiopharmaceuticals in Nuclear Medicine Market Trend Analysis
    9.1.1 Global 2018-2023 Radiopharmaceuticals in Nuclear Medicine Market Size (Volume and Value) Forecast
    9.1.2 Global 2018-2023 Radiopharmaceuticals in Nuclear Medicine Sales Price Forecast
    9.2 Radiopharmaceuticals in Nuclear Medicine Regional Market Trend
    9.2.1 North America 2018-2023 Radiopharmaceuticals in Nuclear Medicine Consumption Forecast
    9.2.2 Europe 2018-2023 Radiopharmaceuticals in Nuclear Medicine Consumption Forecast
    9.2.3 China 2018-2023 Radiopharmaceuticals in Nuclear Medicine Consumption Forecast
    9.2.4 Japan 2018-2023 Radiopharmaceuticals in Nuclear Medicine Consumption Forecast
    9.2.5 Southeast Asia 2018-2023 Radiopharmaceuticals in Nuclear Medicine Consumption Forecast
    9.2.6 India 2018-2023 Radiopharmaceuticals in Nuclear Medicine Consumption Forecast
    9.3 Radiopharmaceuticals in Nuclear Medicine Market Trend (Product Type)
    9.4 Radiopharmaceuticals in Nuclear Medicine Market Trend (Application)

    10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
    10.1.1 Direct Marketing
    10.1.2 Indirect Marketing
    10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
    10.2.1 Pricing Strategy
    10.2.2 Brand Strategy
    10.2.3 Target Client
    10.3 Distributors/Traders List

    11 Radiopharmaceuticals in Nuclear Medicine Marketing Type Analysis
    11.1 Radiopharmaceuticals in Nuclear Medicine Regional Marketing Type Analysis
    11.2 Radiopharmaceuticals in Nuclear Medicine International Trade Type Analysis
    11.3 Traders or Distributors with Contact Information of Radiopharmaceuticals in Nuclear Medicine by Region
    11.4 Radiopharmaceuticals in Nuclear Medicine Supply Chain Analysis

    12 Consumers Analysis of Radiopharmaceuticals in Nuclear Medicine
    12.1 Consumer 1 Analysis
    12.2 Consumer 2 Analysis
    12.3 Consumer 3 Analysis
    12.4 Consumer 4 Analysis

    13 Conclusion of the Global Radiopharmaceuticals in Nuclear Medicine Market Professional Survey Report 2018

    14 Methodology and Data Source
    14.1 Methodology/Research Approach
    14.1.1 Research Programs/Design
    14.1.2 Market Size Estimation
    14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
    14.2.1 Secondary Sources
    14.2.2 Primary Sources
    14.3 Disclaimer
    14.4 Author List

  • Pre-sales Enquiry

    The free sample report is clearly a representation of the complete report. Buy report to get the complete market scope/data depth information.

Related Products
$2500 - $5000 - $5000
Publisher : 99Strategy Publication Date : Sep 16, 2018

Number of Pages : 97 Subcategory : Pharmaceuticals